Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Debt Ratio (2023 - 2026)

Tevogen's (TVGN) quarterly Debt Ratio came in at 1.64 in Q1 2026, up 43.28% on a YoY basis from 1.14 in Q1 2025, and up 18.51% quarter-over-quarter from 1.38 in Q4 2025.

Analysis

Tevogen (TVGN) Debt Ratio (2023 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Debt Ratio for 4 consecutive years, with 1.64 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio rose 43.28% year-over-year to 1.64; the trailing twelve-month figure through Mar 2026 stood at 1.64 (up 43.28% YoY), and the FY2025 full-year result was 1.38, up 80.27% from the prior year.
  • Debt Ratio grew to 1.64 in Q1 2026 per TVGN's latest filing, from 1.38 in the prior quarter.
  • Across five years, Debt Ratio topped out at 14.66 in Q4 2023 and bottomed at 0.02 in Q3 2023.
  • Historically, Debt Ratio has averaged 2.0 across 4 years, with a median of 0.95 in 2025.
  • The widest YoY moves for Debt Ratio: up 2520.88% in 2024, down 94.78% in 2024.
  • Over 4 years, Debt Ratio stood at 14.66 in 2023, then slumped by 94.78% to 0.77 in 2024, then jumped by 80.27% to 1.38 in 2025, then rose by 18.51% to 1.64 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 1.64, 1.38, and 1.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 0.22
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn -
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 0.09
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 0.05
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 0.08
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 0.55
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 0.27
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.64
Dec 31, 2025 1.38
Sep 30, 2025 1.35
Jun 30, 2025 1.42
Mar 31, 2025 1.14
Dec 31, 2024 0.77
Sep 30, 2024 0.62
Jun 30, 2024 0.50
Mar 31, 2024 0.49
Dec 31, 2023 14.66
Sep 30, 2023 0.02
Jun 30, 2023 0.02